Patents by Inventor Anna Johnson

Anna Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260164188
    Abstract: Embodiments are directed to measuring, on a periodic basis by a hearing device, one or more transfer functions, each of the one or more transfer functions comprising a receiver-to-microphone acoustic transfer function of the hearing device. A plurality of health indicators of the hearing device are calculated over time using a measured characteristic of each of the measured transfer functions and a nominal characteristic of each of the measured transfer functions. Using the plurality of health indicators, degradation or failure of any of the receivers, any of the microphones, or a component in an acoustic path between one or more receivers and one or more microphones is detected. One or both of recommended actions and warnings are generated in response to detecting degradation or failure of any of the receivers, any of the microphones, or the component.
    Type: Application
    Filed: December 5, 2025
    Publication date: June 11, 2026
    Inventors: Piero Iared Rivera Benois, Henning Schepker, Anna Johnson, Amit Shahar, Jacques Grange, Martin McKinney, Kenneth Kragh Jensen, Lue Du, Xiaojian Lu, Jeffrey Mullins
  • Publication number: 20250347240
    Abstract: A mixer assembly for mixing, in a mixing tube of an exhaust aftertreatment system, a reductant with an exhaust gas from an internal combustion engine may include a mixer and an electrically heated heating element. The mixer may be positioned in proximity to the reductant injector. The electrically heated heating element may be positioned in proximity to an impingement surface of the mixer. The reductant may directly impinge, after being injected, on the impingement surface causing the reductant to vaporize and mix with the exhaust gas forming a vaporized reductant and exhaust gas mixtures that flows along a flow path defined by the mixing tube. The vaporized reductant and exhaust gas mixture may be heated and further mixed by the electrically heated heating element.
    Type: Application
    Filed: May 10, 2024
    Publication date: November 13, 2025
    Applicant: Caterpillar Inc.
    Inventors: Yong YI, Ryan James KOMINKIEWICZ, Brandon NEUHOFF, Anna JOHNSON
  • Patent number: 12467396
    Abstract: A mixer assembly for mixing, in a mixing tube of an exhaust aftertreatment system, a reductant with an exhaust gas from an internal combustion engine may include a mixer and an electrically heated heating element. The mixer may be positioned in proximity to the reductant injector. The electrically heated heating element may be positioned in proximity to an impingement surface of the mixer. The reductant may directly impinge, after being injected, on the impingement surface causing the reductant to vaporize and mix with the exhaust gas forming a vaporized reductant and exhaust gas mixtures that flows along a flow path defined by the mixing tube. The vaporized reductant and exhaust gas mixture may be heated and further mixed by the electrically heated heating element.
    Type: Grant
    Filed: May 10, 2024
    Date of Patent: November 11, 2025
    Assignee: Caterpillar Inc.
    Inventors: Yong Yi, Ryan James Kominkiewicz, Brandon Neuhoff, Anna Johnson
  • Patent number: 7956047
    Abstract: The present invention comprises the use of chondroitin sulphate (CS-E) or an active fragment thereof for the treatment of diseases or conditions related to collagen fibril formation. Said compounds can be administrated either by oral, topical, injectable or by any other suitable route.
    Type: Grant
    Filed: April 26, 2005
    Date of Patent: June 7, 2011
    Assignee: AnaMar AB
    Inventors: Anders Aspberg, Dick HeinegÄrd, Anna Johnson, Alexander Kvist
  • Publication number: 20080200426
    Abstract: The present invention comprises the use of chondroitin sulphate (CS-E) or an active fragment thereof for the treatment of diseases or conditions related to collagen fibril formation. Said compounds can be administrated either by oral, topical, injectable or by any other suitable route.
    Type: Application
    Filed: April 26, 2005
    Publication date: August 21, 2008
    Inventors: Anders Aspberg, Dick Heinegard, Anna Johnson, Alexander Kvist